Contact us for competitive discounts on bulk quantities
Biological Activity:
Vadimezan or ASA404 (originally DMXAA)is a tumor-vascular disrupting agent(tumor-VDA) that attacks the blood supply of a cancerous tumor to cause tumor regression.It is being studied for the treatment of prostate cancer and HER2 -negative metastatic breast cancer.
References:
Tang CK et al.The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant.PLoS One8:e60038 (2013).